We are live on ! Find out more
SYRS icon

Syros Pharmaceuticals, Inc. Common Stock

Delisted

SYRS was delisted on the 19th of March, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$63.7M +$4.91K +52 +0%
Nikko Asset Management Americas
2
Nikko Asset Management Americas
New York
$48.1M +$15.5M +164,601 +55%
Sumitomo Mitsui Trust Group
3
Sumitomo Mitsui Trust Group
Japan
$48.1M +$28.8M +304,472 +192%
RG
4
Redmile Group
California
$40.4M +$2.53M +26,837 +7%
AVM
5
Arch Venture Management
Illinois
$40M +$36.4M +385,505 New
ARK Investment Management
6
ARK Investment Management
Florida
$39.8M +$406K +4,297 +1%
FP
7
Flagship Pioneering
Massachusetts
$30.5M -$2.51M -26,595 -8%
BlackRock
8
BlackRock
New York
$28.5M +$733K +7,760 +3%
Vanguard Group
9
Vanguard Group
Pennsylvania
$18.6M +$290K +3,068 +2%
SB
10
Samsara BioCapital
California
$17M – – –
Deerfield Management
11
Deerfield Management
New York
$13.2M – – –
BBA
12
Baker Bros. Advisors
New York
$10.1M – – –
State Street
13
State Street
Massachusetts
$7M +$1.05M +11,093 +20%
Dimensional Fund Advisors
14
Dimensional Fund Advisors
Texas
$4.93M – – –
Geode Capital Management
15
Geode Capital Management
Massachusetts
$4.68M +$52K +551 +1%
6CM
16
683 Capital Management
New York
$4.46M – – –
Northern Trust
17
Northern Trust
Illinois
$4.43M +$899K +9,520 +29%
JP Morgan Chase
18
JP Morgan Chase
New York
$4.37M +$120K +1,275 +3%
Renaissance Technologies
19
Renaissance Technologies
New York
$2.98M -$102K -1,080 -4%
Charles Schwab
20
Charles Schwab
California
$2.07M -$46.1K -488 -2%
Candriam SCA
21
Candriam SCA
Luxembourg
$1.75M – – –
Bank of New York Mellon
22
Bank of New York Mellon
New York
$1.16M +$52.5K +556 +5%
Nuveen
23
Nuveen
North Carolina
$1.12M -$41.2K -436 -4%
T. Rowe Price Associates
24
T. Rowe Price Associates
Maryland
$801K -$616K -6,527 -46%
Invesco
25
Invesco
Georgia
$801K +$729K +7,721 New